APRI -- $2.59, up another 6.6% (near open it hit 52-week high of 2.75) as it continues strong upward move on big volume (over 1M traded thus far today). Activist hedge-fund Sarissa / Dr. Denner's involvement with this one bodes well, imo, since he'll bring lots of interest from fellow institutions to this name which seems to have been very much neglected by North American investors the past few years since Vitaros (ED med) was approved in Europe (and Canada) but not here in USA. Their expanded pipeline will certainly be relevant for USA, not just Europe.
Amazing run since Dec. 31 when one could buy this in the 90 cents area.
Wish i had as many shares in this as when i first took solid position in mid-2013!
News 
Market Data 
Discover 
